SUSAN FRANKOVICH: Open Payments
NPI 1174516702 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 17 payments from 13 companies in 2025. Trend: 2023 $538 · 2024 $1,468 · 2025 $1,943
Food & beverage: $1,943
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $387 |
| E.R. Squibb & Sons, L.L.C. | 2 | $250 |
| ABBVIE INC. | 2 | $218 |
| Amgen Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
| Abbott Laboratories | 1 | $103 |
Products named: COBENFY, INVEGA SUSTENNA, SPRAVATO, REPATHA, Wegovy, QULIPTA, INGREZZA, Ohtuvayre.
Industry payments across WA — which companies pay providers there.
